SCHEMBL5324372

SCHEMBL5324372

Clc1ccc(-c2cnc3nc(-c4ccc(Cl)cc4)c(-c4ccc(Cl)cc4)n3c2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 5/20 0.55
AKT2 P31751 5/20 0.55
RAB9A P51151 4/20 0.47
SMN1; SMN2 Q16637 4/20 0.47
KDM4E B2RXH2 2/20 0.47
GAA P10253 2/20 0.47
ALDH1A1 P00352 1/20 0.47
GLA P06280 1/20 0.47
PTGS2 P35354 1/20 0.43
GRM5 P41594 1/20 0.41
NPC1 O15118 3/20 0.39
MAPT P10636 2/20 0.39
PKM P14618 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.38
LMNA P02545 1/20 0.38
KMT2A Q03164 1/20 0.38
ADORA3 P0DMS8 1/20 0.37
KDR P35968 1/20 0.37
CNR1 P21554 1/20 0.36
CHEK2 O96017 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5321323 0.93 AKT1 (0.50) AKT1AKT2RAB9ASMN1; SMN2KDM4E
SCHEMBL5325683 0.88 AKT1 (0.51) AKT1AKT2RAB9ASMN1; SMN2KDM4E
SCHEMBL5320129 0.88 AKT1 (0.46) AKT1AKT2RAB9ASMN1; SMN2KDM4E
SCHEMBL5337798 0.87 AKT1 (0.45) AKT1AKT2RAB9ASMN1; SMN2KDM4E
SCHEMBL5322366 0.87 AKT1 (0.50) AKT1AKT2RAB9ASMN1; SMN2KDM4E
SCHEMBL5341386 0.86 AKT1 (0.49) AKT1AKT2RAB9ASMN1; SMN2KDM4E
SCHEMBL5343647 0.85 AKT1 (0.48) AKT1AKT2RAB9ASMN1; SMN2KDM4E
SCHEMBL5347663 0.85 KDM4E (0.44) AKT1AKT2RAB9ASMN1; SMN2KDM4E
SCHEMBL5349048 0.85 AKT1 (0.48) AKT1AKT2RAB9ASMN1; SMN2KDM4E
SCHEMBL5322231 0.85 AKT1 (0.48) AKT1AKT2RAB9ASMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007096764-A2 BICYCLIC HETEROARYL DERIVATIVES AS CANNABINOID RECEPTOR MODULATORS GLENMARK PHARMACEUTICALS S.A. (US) 2007-08-30 WO claimed
WO-2007096764-A2 BICYCLIC HETEROARYL DERIVATIVES AS CANNABINOID RECEPTOR MODULATORS GLENMARK PHARMACEUTICALS S.A. (US) 2007-08-30 WO disclosed